Furthermore, βig-h3 level could be assessed at diagnosis in PDAC patients at high-risk (i.e., patients >50 years with new onset of diabetes, patients who smoke tobacco, patients with known BRCA germline mutation, etc.). This evidence concerns the gene TGFBI and diabetes mellitus.